Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R5RW
|
|||
| Former ID |
DNC014183
|
|||
| Drug Name |
4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate
|
|||
| Synonyms |
CHEMBL597700; 4-Nitrophenyl 4-Benzylpiperazine-1-carboxylate; SCHEMBL12794615
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H19N3O4
|
|||
| Canonical SMILES |
C1CN(CCN1CC2=CC=CC=C2)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-]
|
|||
| InChI |
1S/C18H19N3O4/c22-18(25-17-8-6-16(7-9-17)21(23)24)20-12-10-19(11-13-20)14-15-4-2-1-3-5-15/h1-9H,10-14H2
|
|||
| InChIKey |
HNIDATBYDXCKRE-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases. J Med Chem. 2010 Feb 25;53(4):1830-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.